Unknown

Dataset Information

0

Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling.


ABSTRACT: Interleukin (IL)-33 is a cytokine of the IL-1 family, which signals through the ST2 receptor. Previous work demonstrated that the systemic administration of recombinant IL-33 reduces the development of atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice by inducing a Th1-to-Th2 shift. The objective of our study was to examine the role of endogenous IL-33 and ST2 in atherosclerosis. ApoE(-/-), IL-33(-/-)ApoE(-/-), and ST2(-/-)ApoE(-/-) mice were fed with a cholesterol-rich diet for 10 weeks. Additionally, a group of ApoE(-/-) mice was injected with a neutralizing anti-ST2 or an isotype control antibody during the period of the cholesterol-rich diet. Atherosclerotic lesion development was measured by Oil Red O staining in the thoracic-abdominal aorta and the aortic sinus. There were no significant differences in the lipid-staining area of IL-33(-/-)ApoE(-/-), ST2(-/-)ApoE(-/-), or anti-ST2 antibody-treated ApoE(-/-) mice, compared to ApoE(-/-) controls. The absence of IL-33 signaling had no major and consistent impact on the Th1/Th2 cytokine responses in the supernatant of in vitro-stimulated lymph node cells. In summary, deficiency of the endogenously produced IL-33 and its receptor ST2 does not impact the development of atherosclerosis in ApoE-deficient mice.

SUBMITTER: Martin P 

PROVIDER: S-EPMC4578523 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling.

Martin Praxedis P   Palmer Gaby G   Rodriguez Emiliana E   Woldt Estelle E   Mean Isabelle I   James Richard W RW   Smith Dirk E DE   Kwak Brenda R BR   Gabay Cem C  

Immunity, inflammation and disease 20150510 3


Interleukin (IL)-33 is a cytokine of the IL-1 family, which signals through the ST2 receptor. Previous work demonstrated that the systemic administration of recombinant IL-33 reduces the development of atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice by inducing a Th1-to-Th2 shift. The objective of our study was to examine the role of endogenous IL-33 and ST2 in atherosclerosis. ApoE(-/-), IL-33(-/-)ApoE(-/-), and ST2(-/-)ApoE(-/-) mice were fed with a cholesterol-rich diet for 10  ...[more]

Similar Datasets

| S-EPMC8207976 | biostudies-literature
| S-EPMC6402609 | biostudies-literature
| S-EPMC3672723 | biostudies-literature
| S-EPMC6367255 | biostudies-literature
| S-EPMC3784527 | biostudies-literature
| S-EPMC6207585 | biostudies-other
| S-EPMC1865027 | biostudies-literature
| S-EPMC5087075 | biostudies-literature
| S-EPMC6462251 | biostudies-literature
| S-EPMC7129023 | biostudies-literature